BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 23838657)

  • 1. Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study.
    Brambilla G; Bombelli M; Seravalle G; Cifkova R; Laurent S; Narkiewicz K; Facchetti R; Redon J; Mancia G; Grassi G
    J Hypertens; 2013 Oct; 31(10):2018-24. PubMed ID: 23838657
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood pressure control and cardiovascular risk profile in hypertensive patients from central and eastern European countries: results of the BP-CARE study.
    Grassi G; Cifkova R; Laurent S; Narkiewicz K; Redon J; Farsang C; Viigimaa M; Erdine S; Brambilla G; Bombelli M; Dell'Oro R; Notari M; Mancia G
    Eur Heart J; 2011 Jan; 32(2):218-25. PubMed ID: 21047877
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and clinical characteristics of isolated-office and true resistant hypertension determined by ambulatory blood pressure monitoring.
    Ríos MT; Domínguez-Sardiña M; Ayala DE; Gomara S; Sineiro E; Pousa L; Callejas PA; Fontao MJ; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):207-20. PubMed ID: 23077975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect.
    Hernández-delRey R; Armario P; Martin-Baranera M; Sánchez P; Cárdenas G; Pardell H
    Blood Press Monit; 1998; 3(6):331-7. PubMed ID: 10212374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Profile on circadian blood pressure and the influencing factors in essential hypertensive patients after treatment].
    Qiu YG; Yao XY; Tao QM; Zheng P; Chen JZ; Zhu JH; Zhang FR; Zheng LR; Zhao LL
    Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Aug; 25(8):710-4. PubMed ID: 15555399
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and clinical profile of resistant hypertension among treated hypertensive subjects.
    Barochiner J; Alfie J; Aparicio LS; Cuffaro PE; Rada MA; Morales MS; Galarza CR; Waisman GD
    Clin Exp Hypertens; 2013; 35(6):412-7. PubMed ID: 23148480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resistant hypertension: a practical clinical approach.
    Muxfeldt ES; de Souza F; Salles GF
    J Hum Hypertens; 2013 Nov; 27(11):657-62. PubMed ID: 23636008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment-time regimen of hypertension medications significantly affects ambulatory blood pressure and clinical characteristics of patients with resistant hypertension.
    Hermida RC; Ríos MT; Crespo JJ; Moyá A; Domínguez-Sardiña M; Otero A; Sánchez JJ; Mojón A; Fernández JR; Ayala DE;
    Chronobiol Int; 2013 Mar; 30(1-2):192-206. PubMed ID: 23098160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White coat effect and masked uncontrolled hypertension in treated hypertensive-diabetic patients: Prevalence and target organ damage.
    Leiria LF; Severo MD; Ledur PS; Becker AD; Aguiar FM; Massierer D; Freitas VC; Schaan BD; Gus M
    J Diabetes; 2015 Sep; 7(5):699-707. PubMed ID: 25327439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs.
    de la Sierra A; Banegas JR; Oliveras A; Gorostidi M; Segura J; de la Cruz JJ; Armario P; Ruilope LM
    J Hypertens; 2012 Jun; 30(6):1211-6. PubMed ID: 22525201
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Factors associated with uncontrolled hypertension in patients with and without cardiovascular disease].
    Cordero A; Bertomeu-Martínez V; Mazón P; Fácila L; Bertomeu-González V; Cosín J; Galve E; Núñez J; Lekuona I; González-Juanatey JR
    Rev Esp Cardiol; 2011 Jul; 64(7):587-93. PubMed ID: 21640460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of masked hypertension in hypertensive patients treated in a primary care setting.
    Andalib A; Akhtari S; Rigal R; Curnew G; Leclerc JM; Vaillancourt M; Tardif JC
    Intern Med J; 2012 Mar; 42(3):260-6. PubMed ID: 21118414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ambulatory hypertensive patients treated by cardiologists in France.
    Blacher J; Peroz-Froz J; Huberman JP; Ferrini M; Jullien G; Guenoun M; Guedj-Meynier D
    Arch Cardiovasc Dis; 2013 Feb; 106(2):86-92. PubMed ID: 23527912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships of different blood pressure categories to indices of inflammation and platelet activity in sustained hypertensive patients with uncontrolled office blood pressure.
    Erdogan D; Icli A; Aksoy F; Akcay S; Ozaydin M; Ersoy I; Varol E; Dogan A
    Chronobiol Int; 2013 Oct; 30(8):973-80. PubMed ID: 23834704
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension difficult to control in the elderly patient. The significance of the "white coat effect"].
    Amado P; Vasconcelos N; Santos I; Almeida L; Nazaré J; Carmona J
    Rev Port Cardiol; 1999 Oct; 18(10):897-906. PubMed ID: 10590654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of time-of-day of hypertension treatment on ambulatory blood pressure and clinical characteristics of patients with type 2 diabetes.
    Moyá A; Crespo JJ; Ayala DE; Ríos MT; Pousa L; Callejas PA; Salgado JL; Mojón A; Fernández JR; Hermida RC;
    Chronobiol Int; 2013 Mar; 30(1-2):116-31. PubMed ID: 23181613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pulse pressure or dipping pattern: which one is a better cardiovascular risk marker in resistant hypertension?
    Muxfeldt ES; Salles GF
    J Hypertens; 2008 May; 26(5):878-84. PubMed ID: 18398329
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of metabolic syndrome in uncontrolled hypertension across Europe: the Global Cardiometabolic Risk Profile in Patients with hypertension disease survey.
    Kjeldsen SE; Naditch-Brule L; Perlini S; Zidek W; Farsang C
    J Hypertens; 2008 Oct; 26(10):2064-70. PubMed ID: 18806632
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of age and hypertension treatment-time on ambulatory blood pressure in hypertensive patients.
    Hermida RC; Ayala DE; Crespo JJ; Mojón A; Chayán L; Fontao MJ; Fernández JR
    Chronobiol Int; 2013 Mar; 30(1-2):176-91. PubMed ID: 23077974
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [District program to improve the cardiovascular risk of resistant hypertensive patients in general medicine].
    Denolle T; Eon Y; Le Néel H; Seignard H; Battini J
    Arch Mal Coeur Vaiss; 2005; 98(7-8):761-6. PubMed ID: 16220744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.